Bhalla Narinder Pal
Chief Medical Officer
Bhalla Narinder Pal has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Jul 1, 2026.
On the most recent filing, Bhalla Narinder Pal is listed as Chief Medical Officer at Lexeo Therapeutics, Inc. Inside the rolling window, Bhalla Narinder Pal reported no open-market purchases and 1 open-market sale totaling $99K in LXEO.
Companies traded
Other insiders at LXEO
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$99K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Bhalla Narinder Pal made?
Bhalla Narinder Pal has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.
Which companies does Bhalla Narinder Pal trade?
Bhalla Narinder Pal has filed SEC Form 4 disclosures for 1 company, including LXEO.
When was Bhalla Narinder Pal's most recent SEC Form 4 filing?
Bhalla Narinder Pal's most recent SEC Form 4 filing on Tracefour is dated Jul 1, 2026.
What is Bhalla Narinder Pal's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Bhalla Narinder Pal is listed as Chief Medical Officer.
What is Bhalla Narinder Pal's total buy and sell value in the current window?
Inside the rolling retention window, Bhalla Narinder Pal bought $0 and sold $99K based on SEC Form 4 filings.
What was Bhalla Narinder Pal's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 22,306 LXEO shares on 2026-07-01, worth $99K, per SEC Form 4 filings.